Real-time enrollment status for this li-fraumeni syndrome clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:17 PM UTC
| NCT Number | NCT04541654 |
| Recruiting Status | Recruiting |
| Condition | Li-Fraumeni Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 1,500 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | March 27, 2026 (Mar 27, 2026) |
As of July 13, 2026: Clinical trial NCT04541654 is currently recruiting participants. This clinical trial study for li-fraumeni syndrome is actively seeking new participants at 3 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04541654 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04541654 was last updated Mar 27, 2026 (March 27, 2026). HelloStudys verifies this status automatically.